Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MB07811 in Primary Hypercholesterolemia
NCT00879112Phase 2Withdrawn
- Sponsor
- Ligand Pharmaceuticals
- Start
- Apr 2009
- Primary completion
- Dec 2009
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VK2809 in hypercholesterolemia, sponsored by Ligand Pharmaceuticals. Planned start Apr 2009; status: withdrawn.
02
Drugs
VK2809
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00879112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00879112.